サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631548

子宮筋腫治療装置の市場規模、シェア、動向分析レポート：テクノロジー別、治療モード別、地域別、セグメント別予測、2025年～2030年

Uterine Fibroids Treatment Devices Market Size, Share & Trends Analysis Report By Technology (Surgical Techniques, Laparoscopic Techniques), By Mode Of Treatment, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
子宮筋腫治療装置の市場規模、シェア、動向分析レポート：テクノロジー別、治療モード別、地域別、セグメント別予測、2025年～2030年
出版日: 2024年12月18日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

子宮筋腫治療装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、子宮筋腫治療装置の世界市場規模は2030年までに121億米ドルに達すると推定され、2025年から2030年にかけて9.4%のCAGRで成長する見込みです。

子宮筋腫患者の増加と、子宮筋腫の診断と治療に関連する意識の高まりが市場を牽引しています。

子宮筋腫（UF）治療のための低侵襲および非侵襲手術は、これらの処置に関連するリスクの低減により人気を集めています。小さな切開は術後の痛みを軽減し、迅速な回復を促進するため、これらの手技の高い採用率につながり、この分野の研究開発の成長を引き起こしています。多くの主要企業が、革新的な低侵襲・非侵襲手術器具の発売に向けて研究開発に投資しています。

さらに、市場参入企業による複数の啓発キャンペーン、新製品の発売、新技術の導入が、予測期間中の市場成長を促進すると予想されます。例えば、Merit Medicalのような企業は、子宮筋腫の認識を広めるだけでなく、手術に代わる安全で効果的な方法を広めることに専念しています。彼らはまた、子宮筋腫と子宮筋腫塞栓術（UFE）の利点に基づいて、インフォグラフィック、パンフレット、月刊記事、ニュースレターなどのAsk4UFE患者教育プログラムを提供しています。

子宮筋腫治療装置市場レポートハイライト：

  • 外科手術技術セグメントは、女性の間で子宮筋腫の罹患率が増加し、効果的な外科的介入が必要になったため、2024年には34.0％の収益シェアで市場を支配しました。
  • アブレーション技術セグメントは、予測期間中に10.4％のCAGRで最も高い成長を遂げると予測されています。
  • 侵襲的治療セグメントは、重度の子宮筋腫の治療におけるその確立された有効性に起因し、2024年に最大の収益シェアで市場を独占しました。
  • 北米の子宮筋腫治療装置市場は、2024年に48.2%の収益シェアを獲得し、世界市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 子宮筋腫治療装置市場の変数、動向、範囲

  • 市場系統の見通し
  • 市場力学
    • 市場ドライバー分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 業界分析- ポーターのファイブフォース分析
    • PESTLE分析

第4章 子宮筋腫治療装置市場：テクノロジーのビジネス分析

  • テクノロジー市場シェア、2024年と2030年
  • テクノロジーセグメントダッシュボード
  • 市場規模と予測および動向分析、テクノロジー別、2018から2030年
  • 外科手術の技術
  • 腹腔鏡技術
  • アブレーション技術
  • 塞栓術

第5章 子宮筋腫治療装置市場：治療モードのビジネス分析

  • 治療モード市場シェア、2024年と2030年
  • 治療モードセグメントダッシュボード
  • 市場規模と予測および動向分析、治療モード別、2018年から2030年
  • 侵襲的治療
  • 低侵襲治療
  • 非侵襲的治療

第6章 子宮筋腫治療装置市場：地域別推定・動向分析

  • 地域別市場シェア分析、2024年および2030年
  • 地域市場ダッシュボード
  • 市場規模と予測動向分析、2018年から2030年：
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
    • ロシア
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
    • コロンビア
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • Medtronic
    • Stryker
    • Boston Scientific Corporation
    • Insightec.
    • CooperSurgical Inc.
    • Hologic, Inc.
    • Lumenis Be Ltd
    • CONMED Corporation.
    • Gynesonics
    • Merit Medical Systems.
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global uterine fibroids treatment devices market, by region, 2018 - 2030 (USD Billion)
  • Table 4 Global uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 5 Global uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 6 North America uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 7 North America uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 8 North America uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 9 U.S. uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 10 U.S. uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 11 Canada uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 12 Canada uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 13 Mexico uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 14 Mexico uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 15 Europe uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 16 Europe uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 17 Europe uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 18 UK uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 19 UK uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 20 Germany uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 21 Germany uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 22 France uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 23 France uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 24 Italy uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 25 Italy uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 26 Spain uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 27 Spain uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 28 Norway uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 29 Norway uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 30 Denmark uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 31 Denmark uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 32 Sweden uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 33 Sweden uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 34 Russia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 35 Russia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 36 Asia Pacific uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 37 Asia Pacific uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 38 Asia Pacific uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 39 Japan uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 40 Japan uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 41 China uterine fibroids treatment devices market, by technology, 2018-2030 (USD Billion)
  • Table 42 China uterine fibroids treatment devices market, by mode of treatment, 2018-2030 (USD Billion)
  • Table 43 India uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 44 India uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 45 Australia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 46 Australia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 47 South Korea uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 48 South Korea uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 49 Thailand uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 50 Thailand uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 51 Latin America uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 52 Latin America uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 53 Latin America uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 54 Brazil uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 55 Brazil uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 56 Argentina uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 57 Argentina uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 58 Colombia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 59 Colombia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 60 Middle East & Africa uterine fibroids treatment devices market, by country, 2018 - 2030 (USD Billion)
  • Table 61 Middle East & Africa uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 62 Middle East & Africa uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 63 South Africa uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 64 South Africa uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 65 Saudi Arabia uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 66 Saudi Arabia uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 67 UAE uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 68 UAE uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)
  • Table 69 Kuwait uterine fibroids treatment devices market, by technology, 2018 - 2030 (USD Billion)
  • Table 70 Kuwait uterine fibroids treatment devices market, by mode of treatment, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Uterine fibroids treatment devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Technology outlook (USD Billion)
  • Fig. 10 Mode of treatment outlook (USD Billion)
  • Fig. 11 Competitive landscape
  • Fig. 12 Uterine fibroids treatment devices market dynamics
  • Fig. 13 Uterine fibroids treatment devices market: Porter's five forces analysis
  • Fig. 14 Uterine fibroids treatment devices market: PESTLE analysis
  • Fig. 15 Uterine fibroids treatment devices market: Technology segment dashboard
  • Fig. 16 Uterine fibroids treatment devices market: Technology market share analysis, 2024 & 2030
  • Fig. 17 Surgical techniques market, 2018 - 2030 (USD Billion)
  • Fig. 18 Hysterectomy market, 2018 - 2030 (USD Billion)
  • Fig. 19 Myomectomy market, 2018 - 2030 (USD Billion)
  • Fig. 20 Laparoscopic techniques market, 2018 - 2030 (USD Billion)
  • Fig. 21 Laparoscopic myomectomy market, 2018 - 2030 (USD Billion)
  • Fig. 22 Myolysis market, 2018 - 2030 (USD Billion)
  • Fig. 23 Ablation techniques market, 2018 - 2030 (USD Billion)
  • Fig. 24 Microwave ablation market, 2018 - 2030 (USD Billion)
  • Fig. 25 Hydrothermal ablation market, 2018 - 2030 (USD Billion)
  • Fig. 26 Cryoablation market, 2018 - 2030 (USD Billion)
  • Fig. 27 Ultrasound ablation market, 2018 - 2030 (USD Billion)
  • Fig. 28 High intensity focused ultrasound (HIFU) market, 2018 - 2030 (USD Billion)
  • Fig. 29 MRI-guided focused ultrasound (MRgFUS) market, 2018 - 2030 (USD Billion)
  • Fig. 30 Embolization techniques market, 2018 - 2030 (USD Billion)
  • Fig. 31 Uterine fibroids treatment devices market: Mode of treatment segment dashboard
  • Fig. 32 Uterine fibroids treatment devices market: Mode of treatment market share analysis, 2024 & 2030
  • Fig. 33 Invasive treatment market, 2018 - 2030 (USD Billion)
  • Fig. 34 Minimally invasive treatment market, 2018 - 2030 (USD Billion)
  • Fig. 35 Non-invasive Treatment market, 2018 - 2030 (USD Billion)
  • Fig. 36 Uterine fibroids treatment devices market revenue, by region
  • Fig. 37 Regional marketplace: Key takeaways
  • Fig. 38 North America uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 39 U.S. country dynamics
  • Fig. 40 U.S. uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 41 Canada country dynamics
  • Fig. 42 Canada uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 43 Mexico country dynamics
  • Fig. 44 Mexico uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 45 Europe uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 46 UK country dynamics
  • Fig. 47 UK uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 48 Germany country dynamics
  • Fig. 49 Germany uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 50 France country dynamics
  • Fig. 51 France uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 52 Italy country dynamics
  • Fig. 53 Italy uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 54 Spain country dynamics
  • Fig. 55 Spain uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 56 Norway country dynamics
  • Fig. 57 Norway uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 58 Denmark country dynamics
  • Fig. 59 Denmark uterine fibroids treatment devices market, 2018 - 2030 (USD Billion
  • Fig. 60 Sweden country dynamics
  • Fig. 61 Sweden uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 62 Russia country dynamics
  • Fig. 63 Russia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 64 Asia Pacific uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 65 Japan country dynamics
  • Fig. 66 Japan uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 67 China country dynamics
  • Fig. 68 China uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 69 India country dynamics
  • Fig. 70 India uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 71 South Korea country dynamics
  • Fig. 72 South Korea uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 73 Australia country dynamics
  • Fig. 74 Australia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 75 Thailand country dynamics
  • Fig. 76 Thailand uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 77 Latin America uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 78 Brazil country dynamics
  • Fig. 79 Brazil uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 80 Argentina country dynamics
  • Fig. 81 Argentina uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 82 Colombia country dynamics
  • Fig. 83 Colombia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 84 MEA uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 85 South Africa country dynamics
  • Fig. 86 South Africa uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 87 Saudi Arabia country dynamics
  • Fig. 88 Saudi Arabia uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 89 UAE country dynamics
  • Fig. 90 UAE uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 91 Kuwait country dynamics
  • Fig. 92 Kuwait uterine fibroids treatment devices market, 2018 - 2030 (USD Billion)
  • Fig. 93 Company categorization
  • Fig. 94 Company market position analysis
  • Fig. 95 Strategic framework
目次
Product Code: GVR-4-68038-820-6

Uterine Fibroids Treatment Devices Market Growth & Trends:

The global uterine fibroids treatment devices market size is estimated to reach USD 12.1 billion by 2030, registering to grow at a CAGR of 9.4% from 2025 to 2030 according to a new report by Grand View Research, Inc. An increasing population of uterine fibroids patients and rising awareness initiatives related to fibroids diagnosis and treatment are driving the market.

Minimally invasive and non-invasive surgeries for the treatment of Uterine Fibroids (UF) are gaining popularity owing to the reduced risk associated with these procedures. Smaller incisions decrease post-operative pain and facilitate speedy recovery, thus leading to high adoption of these procedures and triggering the growth of R&D in this field. Many key players are investing in research and development for the launch of innovative minimally and non-invasive surgical instruments.

Furthermore, several awareness campaigns, new product launches, and incorporation of new technologies by market players are expected to fuel the market growth during the forecast period. For instance, companies such as Merit Medical are dedicated to spreading fibroid awareness as well as promoting a safe and effective alternative to surgery. They also provide Ask4UFE patient educational programs, such as infographics, brochures, monthly articles, and newsletters, based on uterine fibroids and the benefits of uterine fibroid embolization (UFE).

Uterine Fibroids Treatment Devices Market Report Highlights:

  • The surgical techniques segment dominated the market with a revenue share of 34.0% in 2024, attributed to the increasing prevalence of uterine fibroids among women, necessitating effective surgical interventions.
  • The ablation techniques segment is projected to grow at the highest CAGR of 10.4% over the forecast period.
  • The invasive treatment segment dominated the market with the largest revenue share in 2024, attributed to its established efficacy in treating severe uterine fibroids.
  • North America uterine fibroids treatment devices market dominated the global market, with a revenue share of 48.2% in 2024, driven by high healthcare spending and advanced medical infrastructure.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Mode of Treatment
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Uterine Fibroids Treatment Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Uterine Fibroids Treatment Devices Market: Technology Business Analysis

  • 4.1. Technology Market Share, 2024 & 2030
  • 4.2. Technology Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
  • 4.4. Surgical Techniques
    • 4.4.1. Surgical Techniques Market, 2018 - 2030 (USD Billion)
    • 4.4.2. Hysterectomy
      • 4.4.2.1. Hysterectomy Market, 2018 - 2030 (USD Billion)
    • 4.4.3. Myomectomy
      • 4.4.3.1. Myomectomy Market, 2018 - 2030 (USD Billion)
  • 4.5. Laparoscopic Techniques
    • 4.5.1. Laparoscopic Techniques Market, 2018 - 2030 (USD Billion)
    • 4.5.2. Laparoscopic Myotectomy
      • 4.5.2.1. Laparoscopic Myotectomy Market, 2018 - 2030 (USD Billion)
    • 4.5.3. Myolysis
      • 4.5.3.1. Myolysis Market, 2018 - 2030 (USD Billion)
  • 4.6. Ablation Techniques
    • 4.6.1. Ablation Techniques Market, 2018 - 2030 (USD Billion)
    • 4.6.2. Microwave Ablation
      • 4.6.2.1. Microwave Ablation Market, 2018 - 2030 (USD Billion)
    • 4.6.3. Hydrothermal Ablation
      • 4.6.3.1. Hydrothermal Ablation Market, 2018 - 2030 (USD Billion)
    • 4.6.4. Cryoablation
      • 4.6.4.1. Cryoablation, 2018 - 2030 (USD Billion)
    • 4.6.5. Ultrasound Ablation
      • 4.6.5.1. Ultrasound Ablation Market, 2018 - 2030 (USD Billion)
      • 4.6.5.2. High Intensity Focused Ultrasound (HIFU)
        • 4.6.5.2.1. High Intensity Focused Ultrasound (HIFU) Market, 2018 - 2030 (USD Billion)
      • 4.6.5.3. MRI-guided Focused Ultrasound (MRgFUS)
        • 4.6.5.3.1. MRI-guided Focused Ultrasound (MRgFUS) Market, 2018 - 2030 (USD Billion)
  • 4.7. Embolization Techniques
    • 4.7.1. Embolization Techniques Market, 2018 - 2030 (USD Billion)

Chapter 5. Uterine Fibroids Treatment Devices Market: Mode of Treatment Business Analysis

  • 5.1. Mode of Treatment Market Share, 2024 & 2030
  • 5.2. Mode of Treatment Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Mode of Treatment, 2018 to 2030 (USD Billion)
  • 5.4. Invasive Treatment
    • 5.4.1. Invasive Treatment Market, 2018 - 2030 (USD Billion)
  • 5.5. Minimally Invasive Treatment
    • 5.5.1. Minimally Invasive Treatment Market, 2018 - 2030 (USD Billion)
  • 5.6. Non-invasive Treatment
    • 5.6.1. Non-invasive Treatment Market, 2018 - 2030 (USD Billion)

Chapter 6. Uterine Fibroids Treatment Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Canada Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.5. Europe
    • 6.5.1. Europe Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Uterine Fibroids Treatment Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
    • 6.5.10. Russia
      • 6.5.10.1. Key Country Dynamics
      • 6.5.10.2. Regulatory Framework
      • 6.5.10.3. Competitive Insights
      • 6.5.10.4. Russia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Billion)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Latin America
    • 6.7.1. Latin America Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.7.4. Colombia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Framework
      • 6.7.4.3. Competitive Insights
      • 6.7.4.4. Colombia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. MEA
    • 6.8.1. MEA Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Uterine Fibroids Treatment Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Medtronic
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Technology Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Stryker
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Technology Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Boston Scientific Corporation
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Technology Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Insightec.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Technology Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. CooperSurgical Inc.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Technology Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Hologic, Inc.
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Technology Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Lumenis Be Ltd
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Technology Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. CONMED Corporation.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Technology Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Gynesonics
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Technology Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Merit Medical Systems.
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Technology Benchmarking
      • 7.5.10.4. Strategic Initiatives